what does microdosing glp 1 look like Why GLP-1 Microdosing? A Closer at Reported Benefits Microdosing GLP1: Trend in Weight
Description
In animal models, GLP-1RAs inhibited myocardial fibrosis and reduced ventricular hypertrophy
The clinical data are compelling
After 10 months on Wegovy, this user successfully lost 80 pounds (36.3 kg), going from 250 lbs (113.4 kg) to 170 lbs (77.1 kg)
CON and NOB at 30 and 60 min post-meal (p 0.05)
Clinical studies have demonstrated significant weight loss achieved by semaglutide in individuals without diabetes, making it a valuable potential treatment option for patients struggling with obesity
